# A Study of a Seasonal Trivalent Split, Inactivated Influenza Vaccine

> **NCT02585700** · PHASE1 · COMPLETED · sponsor: **Institute of Virology, Vaccines and Sera, Torlak** · enrollment: 60 (actual)

## Conditions studied

- Influenza, Human

## Interventions

- **BIOLOGICAL:** Influenza vaccine, split inactivated
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02585700
- **Lead sponsor:** Institute of Virology, Vaccines and Sera, Torlak
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-01-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02585700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02585700, "A Study of a Seasonal Trivalent Split, Inactivated Influenza Vaccine". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT02585700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*